DexCom (DXCM) Fell Due to an Uncharacteristic Earnings Miss [Yahoo! Finance]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Yahoo! Finance
A copy of the letter can be downloaded here . The U.S. equity market continued its rise to new record highs, with the S&P 500 Index increasing by 5.89% during the period. Aristotle Atlantic's Focus Growth strategy returned 2.84% gross of fees (2.82% net of fees) in the quarter underperforming the Russell 1000 Growth Index's 3.19% total return. The relative outperformance was due to both allocation effects and security selection. In addition, you can check the fund's top 5 holdings to determine its best picks for 2024. Aristotle Focus Growth Strategy highlighted stocks like DexCom, Inc. (NASDAQ: DXCM ), in the third quarter 2024 investor letter. DexCom, Inc. (NASDAQ:DXCM) is a medical device company that develops and commercializes continuous glucose monitoring (CGM) systems. The one-month return of DexCom, Inc. (NASDAQ:DXCM) was 3.55%, and its shares lost 27.64% of their value over the last 52 weeks. On October 31, 2024, DexCom, Inc. (NASDAQ:DXCM) stock closed at $70.48 per share wi
Show less
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- Analysts say Dexcom's FDA warning unlikely to impact 2025 revenue [Yahoo! Finance]Yahoo! Finance
- Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't Worried [Yahoo! Finance]Yahoo! Finance
- DexCom, Inc. (NASDAQ: DXCM) had its "overweight" rating re-affirmed by analysts at Wells Fargo & Company.MarketBeat
- DexCom Stock Drops as Diabetes Devices Maker Gets FDA Warning Letter [Yahoo! Finance]Yahoo! Finance
- Dexcom receives warning letter based on FDA inspections of 2 plants [Yahoo! Finance]Yahoo! Finance
DXCM
Earnings
- 2/13/25 - Miss
DXCM
Sec Filings
- 3/11/25 - Form 4
- 3/11/25 - Form 4
- 3/11/25 - Form 4
- DXCM's page on the SEC website